|
June. 22, 2026 |
|
|
June. 22, 2026 |
|
|
jRCT2031260244 |
A Phase III, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of M610101 in Patients with Atopic Dermatitis |
|
A Phase III Study of M610101 in Patients with Atopic Dermatitis |
Nishiura Tomoyuki |
||
Maruho Co.,Ltd. Kyoto R&D Center |
||
93 Chudoji Awatacho, Shimogyo-ku, Kyoto |
||
+81-75-325-3279 |
||
ctinfo@mii.maruho.co.jp |
||
- Clinical Trials Information |
||
Maruho Co.,Ltd. Kyoto R&D Center |
||
93 Chudoji Awatacho, Shimogyo-ku, Kyoto |
||
+81-75-325-3279 |
||
ctinfo@mii.maruho.co.jp |
Recruiting |
June. 22, 2026 |
||
| 150 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
placebo control |
||
parallel assignment |
||
treatment purpose |
||
(1)Patients with atopic dermatitis aged 2 years to 12 years |
||
(1)Patients complicated with diseases considered inappropriate for participation in clinical trials such as serious cardiac / hepatic / renal / pulmonary / hematologic disease |
||
| 2age old over | ||
| 12age old not | ||
Both |
||
Atopic dermatitis |
||
Apply 2 times a day. |
||
Proportion of participants achieving an IGA score of 0 or 1 with at least a 2-point improvement from baseline at week 8 |
||
| Maruho Co.,Ltd. |
| Medical corporation Shintoukai Yokohamaminoru Clinic IRB | |
| 1-13-8, Bessho Minami-ku Yokohama-shi, Kanagawa | |
+81-42-648-5551 |
|
| yminoru-irb@eps.co.jp | |
| Not approval |
No |
none |